Literature DB >> 36102640

Pseudomonas aeruginosa Strains from Both Clinical and Environmental Origins Readily Adopt a Stable Small-Colony-Variant Phenotype Resulting from Single Mutations in c-di-GMP Pathways.

Alison Besse1, Marie-Christine Groleau1, Mylène Trottier1, Antony T Vincent2,3, Eric Déziel1.   

Abstract

A subpopulation of small-colony variants (SCVs) is a frequently observed feature of Pseudomonas aeruginosa isolates obtained from colonized cystic fibrosis lungs. Since most SCVs have until now been isolated from clinical samples, it remains unclear how widespread the ability of P. aeruginosa strains to develop this phenotype is and what the genetic mechanism(s) behind the emergence of SCVs are according to the origin of the isolate. In the present work, we investigated the ability of 22 P. aeruginosa isolates from various environmental origins to spontaneously adopt an SCV-like smaller alternative morphotype distinguishable from that of the ancestral parent strain under laboratory culture conditions. We found that all the P. aeruginosa strains tested could adopt an SCV phenotype, regardless of their origin. Whole-genome sequencing of SCVs obtained from clinical and environmental sources revealed single mutations exclusively in two distinct c-di-GMP signaling pathways, the Wsp and YfiBNR pathways. We conclude that the ability to switch to an SCV phenotype is a conserved feature of P. aeruginosa and results from the acquisition of a stable genetic mutation, regardless of the origin of the strain. IMPORTANCE P. aeruginosa is an opportunistic pathogen that thrives in many environments. It poses a significant health concern, notably because this bacterium is the most prevalent pathogen found in the lungs of people with cystic fibrosis. In infected hosts, its persistence is considered related to the emergence of an alternative small-colony-variant (SCV) phenotype. By reporting the distribution of P. aeruginosa SCVs in various nonclinical environments and the involvement of c-di-GMP in SCV emergence from both clinical and environmental strains, this work contributes to understanding a conserved adaptation mechanism used by P. aeruginosa to adapt readily in all environments. Hindering this adaptation strategy could help control persistent infection by P. aeruginosa.

Entities:  

Keywords:  RSCV; biofilms; microbial adaptation; pellicle; phenotypic variation

Mesh:

Substances:

Year:  2022        PMID: 36102640      PMCID: PMC9578426          DOI: 10.1128/jb.00185-22

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.476


  79 in total

1.  Microbial characterization of biofilms in domestic drains and the establishment of stable biofilm microcosms.

Authors:  Andrew J McBain; Robert G Bartolo; Carl E Catrenich; Duane Charbonneau; Ruth G Ledder; Alexander H Rickard; Sharon A Symmons; Peter Gilbert
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

2.  Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model.

Authors:  Matthew S Byrd; Bing Pang; Wenzhou Hong; Elizabeth A Waligora; Richard A Juneau; Chelsie E Armbruster; Kristen E D Weimer; Kyle Murrah; Ethan E Mann; Haiping Lu; April Sprinkle; Matthew R Parsek; Nancy D Kock; Daniel J Wozniak; W Edward Swords
Journal:  Infect Immun       Date:  2011-06-06       Impact factor: 3.441

Review 3.  DNA rearrangements and phenotypic switching in prokaryotes.

Authors:  K Dybvig
Journal:  Mol Microbiol       Date:  1993-11       Impact factor: 3.501

Review 4.  Pseudomonas aeruginosa: new insights into pathogenesis and host defenses.

Authors:  Shaan L Gellatly; Robert E W Hancock
Journal:  Pathog Dis       Date:  2013-03-15       Impact factor: 3.166

Review 5.  Pseudomonas aeruginosa Biofilm, a Programmed Bacterial Life for Fitness.

Authors:  Keehoon Lee; Sang Sun Yoon
Journal:  J Microbiol Biotechnol       Date:  2017-06-28       Impact factor: 2.351

6.  Biosurfactant production by a soil pseudomonas strain growing on polycyclic aromatic hydrocarbons.

Authors:  E Deziel; G Paquette; R Villemur; F Lepine; J Bisaillon
Journal:  Appl Environ Microbiol       Date:  1996-06       Impact factor: 4.792

7.  YfiBNR mediates cyclic di-GMP dependent small colony variant formation and persistence in Pseudomonas aeruginosa.

Authors:  Jacob G Malone; Tina Jaeger; Christian Spangler; Daniel Ritz; Anne Spang; Cécile Arrieumerlou; Volkhard Kaever; Regine Landmann; Urs Jenal
Journal:  PLoS Pathog       Date:  2010-03-12       Impact factor: 6.823

8.  Pseudomonas aeruginosa rugose small-colony variants have adaptations that likely promote persistence in the cystic fibrosis lung.

Authors:  Melissa Starkey; Jason H Hickman; Luyan Ma; Niu Zhang; Susan De Long; Aaron Hinz; Sergio Palacios; Colin Manoil; Mary Jo Kirisits; Timothy D Starner; Daniel J Wozniak; Caroline S Harwood; Matthew R Parsek
Journal:  J Bacteriol       Date:  2009-03-27       Impact factor: 3.490

9.  Phenotypic and genome-wide analysis of an antibiotic-resistant small colony variant (SCV) of Pseudomonas aeruginosa.

Authors:  Qing Wei; Saeed Tarighi; Andreas Dötsch; Susanne Häussler; Mathias Müsken; Victoria J Wright; Miguel Cámara; Paul Williams; Steven Haenen; Bart Boerjan; Annelies Bogaerts; Evy Vierstraete; Peter Verleyen; Liliane Schoofs; Ronnie Willaert; Valérie N De Groote; Jan Michiels; Ken Vercammen; Aurélie Crabbé; Pierre Cornelis
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

10.  Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat.

Authors:  Stephen P Diggle; Marvin Whiteley
Journal:  Microbiology       Date:  2020-01       Impact factor: 2.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.